Infringement Misappropriation. (i) To ATL’s Knowledge, Cortendo’s exercise of the rights granted under the Licence as permitted under this agreement will not infringe any Third Party’s Intellectual Property Rights. (ii) ATL has not received any written notice from any Third Party asserting or alleging, nor to ATL’s Knowledge is there, any basis for any assertion or allegation, that any use, research, manufacture or development of ATL1103 by ATL prior to the Start Date infringed or misappropriated the Intellectual Property Rights of such Third Party.
Appears in 3 contracts
Sources: Technology Licence Agreement (Strongbridge Biopharma PLC), Technology Licence Agreement (Cortendo AB), Technology Licence Agreement (Cortendo AB)